Distributor Abramorama has received the US distribution rights to RadicalMedia’s production of award-winning director Jake ...

Myriad Genetics, Inc.’s MYGN Oncology growth strategy, which focuses on expanding companion diagnostics and market growth through new clinical guidelines, is poised to drive growth in the upcoming ...

Abramorama has acquired U.S. distribution rights to 'Ron Delsener Presents,' a documentary on the legendary promoter with ...

Genetic engineering in non-human primates has historically faced limitations due to the reliance on virus-based gene delivery methods.

Researchers successfully use a nonviral, piggyBac transposon system to introduce a transgene into cynomolgus monkeys.

Genetic engineering in non-human primates has long been limited by the need for virus-based gene delivery methods. Recently, ...

MeiraGTx's innovative gene therapies for ocular diseases & more are backed by strong clinical data and funding. Click here to find out why MGTX stock is a Buy.

Transgenic animals continue to play an essential role in many aspects of zebrafish research, including the development of disease models. The most widely used system for zebrafish transgenesis is the ...

Researchers at University of Tsukuba have developed a vector that integrates the Cre enzyme gene with the specific DNA ...

Researchers have engineered yeast to efficiently convert methanol into D-lactic acid, a key compound for biodegradable plastics and pharmaceuticals. By optimizing gene and promoter combinations, they ...

D-LDH is a key enzyme responsible for converting precursor molecules into D-lactic acid, while promoters are DNA sequences ...

Zandy Forbes’ biotech company MeiraGTx has developed targeted gene therapy methods to treat more than just genetic disorders. Now it’s on the cusp of its first regulatory approval. Each year ...